M. Ho

Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).

S. Demo, M. Aujay, T. Muchamuel, 2009, Journal of medicinal chemistry.

Glucuronidation of trans‐resveratrol by human liver and intestinal microsomes and UGT isoforms

I. Kapetanovic, L. Iyer, C. Green, 2006, The Journal of pharmacy and pharmacology.

Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.

L. Iyer, C. Green, M. Tanga, 2003, Toxicological sciences : an official journal of the Society of Toxicology.

Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome.

S. Demo, M. Aujay, M. Bennett, 2007, Cancer research.

Approaches to Safe Nanotechnology Managing the Health and Safety Concerns Associated with Engineered Nanomaterials

Welland, C. Branche, M. Ho, 2009 .